Careers

Diversity

With 17 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

Molina takes part in arbitration panel at U.S.-Mexico Bar Association conference

Ohio Clock

Hallway with a grandfather clock displayed

The Weekly Hill Update

It’s official: Former IP Partner John Murphy sworn in as district court judge

Serrato, Saraswat speak at IAPP Privacy. Security. Risk. conference

<p>Partner Lee Rosebush and Associates Lindsay Holmes and Marc Wagner authored an article published Feb. 13, 2020, by the American Health Law Association. The article, “FDA to Convert Some NDAs to BLAs on March 23, 2020,” discusses the March 23 transition date for the “Deemed to be a License” (Deemed BLA) provision of the Biologics Price Competition and Innovation Act of 2009. The authors note that more stakeholders have become interested in the implications of the move to convert New Drug Applications (NDAs) to Biologic License Applications (BLAs) and remove the NDAs from FDA’s Approved Drug Products With Therapeutic Equivalence Evaluations (the “Orange Book”).</p>  <p><a href="https://www.americanhealthlaw.org/content-library/publications/bulletins/70f28297-1a76-4439-b866-4c92b1841dc5/FDA-to-Convert-Some-NDAs-to-BLAs-on-March-23-2020">Read the article (registration required)</a>.</p>




core/freeform

Washington, D.C.

Partner

Lee H. Rosebush

Associate

Marc N. Wagner

Lee Rosebush, Lindsay Holmes, Marc Wagner Article Examines Conversion of Some NDAs to BLAs

Related Services

Featured Insights